[Subglottic tracheal stenosis].

Abstract

OBJECTIVES:

To assess the results of endoscopic CO(2) laser resections combined with mitomycin-C and/or triamcinolone acetonide therapy in the treatment of patients with symptomatic subglottic tracheal stenosis.

MATERIALS AND METHODS:

Eleven patients (all female) with subglottic tracheal stenosis were divided into two groups: six patients with idiopathic subglottic tracheal stenosis and five with subglottic tracheal stenosis of known etiology (four with Wegener's disease and one with polychondritis of the trachea). Three patients showed signs of reflux. The primary outcome measure was improvement of the clinical symptoms and the secondary the postoperative reduction of airway resistance.

RESULTS:

All patients were treated with CO(2) laser resections combined with mitomycin-C and/or triamcinolone acetonide therapy. Postoperative examinations during a period of 7 to 72 months demonstrated a reduction of symptoms and of airway resistance in all patients.

CONCLUSIONS:

One or more endoscopic CO(2) laser resections combined with mitomycin-C and/or triamcinolone acetonide therapy are effective in the treatment of subglottic tracheal stenoses. Long-term oral steroid and immunosuppressive therapy as well as the use of proton pump inhibitors positively influences the postoperative outcome.

• Authors: N Karaiskaki, W J Mann
• Journal: HNO (HNO) Vol. 60 Issue 6 Pg. 505-10 (Jun 2012) ISSN: 1433-0458 [Electronic] Germany
• Vernacular Title: Subglottische Trachealstenosen.
• PMID: 22261849 (Publication Type: Controlled Clinical Trial, English Abstract, Journal Article)

Chemical References

• Immunosuppressive Agents
• Proton Pump Inhibitors

Topics

• Adult
• Aged
• Female
• Humans
• Immunosuppressive Agents (therapeutic use)
• Laser Therapy (methods)
• Lasers, Gas (therapeutic use)
• Middle Aged
• Proton Pump Inhibitors (therapeutic use)
• Tracheal Stenosis (diagnosis, therapy)
• Treatment Outcome